BREAKTHROUGH FOR HPV-UNRELATED HEAD AND NECK SQUAMOUS CELL CARCINOMA

No more options after chemo and immunotherapy? A new bispecific antibody is changing the game for HPV-unrelated head and neck cancer. Patients with HPV-unrelated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) often face rapid progression and very limited options after platinum-based chemotherapy and PD inhibitors. This group represents ∼75% of all cases and has […]